Disposition of 1200000 shares by Topper James N of Alpine Immune at 0.001 subject to Rule 16b-3
ALPNDelisted Stock | USD 12.37 0.23 1.83% |
About 62% of Alpine Immune's investor base is looking to short. The analysis of current outlook of investing in Alpine Immune Sciences suggests that many traders are alarmed regarding Alpine Immune's prospects. Alpine Immune's investing sentiment overview a quick insight into current market opportunities from investing in Alpine Immune Sciences. Many technical investors use Alpine Immune Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Alpine |
Filed transaction by Alpine Immune Sciences Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Alpine Immune Fundamental Analysis
We analyze Alpine Immune's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alpine Immune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alpine Immune based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Alpine Immune is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Alpine Immune Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alpine Immune stock to make a market-neutral strategy. Peer analysis of Alpine Immune could also be used in its relative valuation, which is a method of valuing Alpine Immune by comparing valuation metrics with similar companies.
Peers
Alpine Immune Related Equities
ANEB | Anebulo Pharmaceuticals | 7.64 | ||||
ADAG | Adagene | 6.39 | ||||
TERN | Terns Pharmaceuticals | 3.41 | ||||
ACRV | Acrivon Therapeutics, | 0.13 | ||||
DAWN | Day One | 1.81 | ||||
IGMS | IGM Biosciences | 2.22 | ||||
BCYC | Bicycle Therapeutics | 2.80 | ||||
ABOS | Acumen Pharmaceuticals | 2.98 | ||||
TNYA | Tenaya Therapeutics | 3.35 | ||||
GLUE | Monte Rosa | 3.52 | ||||
AMLX | Amylyx Pharmaceuticals | 3.60 | ||||
MLYS | Mineralys Therapeutics, | 4.60 | ||||
STOK | Stoke Therapeutics | 5.30 | ||||
MLTX | MoonLake Immunotherapeuti | 7.52 | ||||
ANAB | AnaptysBio | 9.76 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Alpine Stock
If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |